Atorable EZ Tablet combines Atorvastatin 10 mg, an HMG-CoA reductase inhibitor, with Ezetimibe 10 mg, a cholesterol absorption inhibitor, to provide comprehensive lipid-lowering therapy. This dual mechanism reduces LDL cholesterol and total cholesterol, while supporting cardiovascular risk reduction.
Belonging to the cardiology and lipid-lowering segment, Atorable EZ is prescribed for patients with hypercholesterolemia, mixed dyslipidemia, and high cardiovascular risk. It is especially effective when monotherapy alone is insufficient to achieve target lipid levels.
The combination therapy improves patient compliance by providing two synergistic agents in a single tablet, reducing pill burden while ensuring consistent cholesterol management.
For PCD pharma franchise partners, distributors, exporters, and third-party manufacturers, Atorable EZ Tablet offers a profitable B2B opportunity, catering to hospitals, clinics, and specialty pharmacies across India, with high and recurring demand in the cardiovascular therapy market.
Common side effects include headache, mild gastrointestinal discomfort, muscle aches, or fatigue. Rare but serious effects may include severe muscle problems (myopathy/rhabdomyolysis), liver enzyme elevation, or allergic reactions. Seek medical attention if you experience severe muscle pain, jaundice, or unusual fatigue.
Atorable EZ Tablet is indicated for the treatment of hypercholesterolemia and mixed dyslipidemia. It helps lower LDL cholesterol, total cholesterol, and triglycerides, while slightly increasing HDL cholesterol, reducing the risk of heart attack, stroke, and atherosclerosis.
Take Atorable EZ Tablet exactly as prescribed, preferably at the same time each day. Inform your doctor if you have liver or kidney disease, are pregnant or breastfeeding, or are taking other cholesterol-lowering medications. Regular monitoring of liver function and lipid levels is recommended.
Store Atorable EZ Tablet in a cool, dry place below 25°C, away from sunlight and moisture. Keep out of reach of children.